NRSF Inhibitors

Common NRSF Inhibitors include, but are not limited to Geneticin (G418) Sulfate CAS 108321-42-2, Valproic Acid CAS 99-66-1, 5-Aza-2′-Deoxycytidine CAS 2353-33-5, MS-275 CAS 209783-80-2 and Suberoylanilide Hydroxamic Acid CAS 149647-78-9.

NRSF inhibitors belong to a chemical class that specifically targets the neuronal restrictive silencing factor (NRSF), also known as RE1-silencing transcription factor (REST). NRSF is a transcriptional repressor that plays a critical role in regulating gene expression in neuronal cells. These inhibitors are designed to bind to NRSF and modulate its activity, thereby interfering with its ability to repress target genes.

NRSF acts as a transcriptional repressor by binding to specific DNA sequences known as RE1 (repressor element 1) sites, located in the regulatory regions of target genes. By binding to these RE1 sites, NRSF recruits co-repressor proteins, which in turn lead to the formation of a complex that inhibits gene transcription. NRSF inhibitors work by binding to NRSF and disrupting its interaction with RE1 sites, thus preventing the recruitment of co-repressors and allowing for the transcription of target genes. Through their specific targeting of NRSF, these inhibitors provide a valuable tool for researchers to investigate the regulatory mechanisms of gene expression in neuronal cells. By interfering with NRSF activity, they offer insights into the roles played by NRSF in neuronal development, plasticity, and function. NRSF inhibitors enable researchers to explore the transcriptional networks and molecular pathways controlled by NRSF, thereby expanding our understanding of gene regulation in the context of the nervous system. Their development and utilization offer new opportunities to decipher the intricate mechanisms underlying neuronal gene expression and the interplay between NRSF and its target genes.